Case Number 6957
Request Date 07/09/2019
Completion Date 19/09/2019

 

Details of the Request

Could you please provide me with the following numbers of patients treated in the last 12 months [latest 12 months possible] with the following drugs for the following conditions.

Treatment:

  • Abatacept (Orencia)
  • Adalimumab biosimilar [Amgevita]
  • Adalimumab biosimilar [Hulio]
  • Adalimumab [Humira]
  • Adalimumab biosimilar [Hyrimoz]
  • Adalimumab biosimilar [Imraldi]
  • Apremilast (Otezla)
  • Baricitinib (Olumiant)
  • Brodalumab (Kyntheum)
  • Certolizumab (Cimzia)
  • Dimethyl Fumarate (Skilarence)
  • Etanercept (Enbrel)
  • Etanercept Biosimilar (Benepali)
  • Etanercept Biosimilar (Erelzi)
  • Golimumab (Simponi)
  • Guselkumab (Tremfya)
  • Infliximab [Flixabi]
  • Infliximab [Inflectra]
  • Infliximab [Remicade]
  • Infliximab [Remsima]
  • Ixekizumab (Taltz)
  • Rituximab (Mabthera)
  • Rituximab Biosimilar (Rixathon)
  • Rituximab Biosimilar (Truxima)
  • Sarilumab (Kevzara)
  • Secukinumab (Cosentyx)
  • Tildrakizumab (Ilumetri)
  • Tocilizumab (Ro Actemra)
  • Tofacitinib (Xeljanz)
  • Ustekinumab (Stelara)
  • Vedolizumab (Entyvio)

 

Details of the Response

The data was run between 09/18 to 08/19.

Treatment Total
Abatacept (Orencia) 12
Adalimumab biosimilar [Amgevita] 0
Adalimumab biosimilar [Hulio] 0
Adalimumab [Humira] 304
Adalimumab biosimilar [Hyrimoz] 0
Adalimumab biosimilar [Imraldi] 191
Apremilast (Otezla) 28
Baricitinib (Olumiant) 0
Brodalumab (Kyntheum) 0
Certolizumab (Cimzia) 65
Dimethyl Fumarate (Skilarence) 3
Etanercept (Enbrel) 8
Etanercept Biosimilar (Benepali) 160
Etanercept Biosimilar (Erelzi) 0
Golimumab (Simponi) 6
Guselkumab (Tremfya) 0
Infliximab [Flixabi] 3
Infliximab [Inflectra] 102
Infliximab [Remicade] 1
Infliximab [Remsima] 0
Ixekizumab (Taltz) 3
Rituximab (Mabthera) 0
Rituximab Biosimilar (Rixathon) 0
Rituximab Biosimilar (Truxima) 27
Sarilumab (Kevzara) 0
Secukinumab (Cosentyx) 39
Tildrakizumab (Ilumetri) 0
Tocilizumab (Ro Actemra) 38
Tofacitinib (Xeljanz) 0
Ustekinumab (Stelara) 44
Vedolizumab (Entyvio) 54

 

Treatment Psoriasis Crohns disease Ulcerative Colitis
Abatacept (Orencia) 12 0 0
Adalimumab biosimilar [Amgevita] 0 0 0
Adalimumab biosimilar [Hulio] 0 0 0
Adalimumab [Humira] 47 55 61
Adalimumab biosimilar [Hyrimoz] 0 0 0
Adalimumab biosimilar [Imraldi] 52 60 55
Apremilast (Otezla) 0 0 3
Baricitinib (Olumiant) 0 0 0
Brodalumab (Kyntheum) 0 0 0
Certolizumab (Cimzia) 53 4 8
Dimethyl Fumarate (Skilarence) 0 0 0
Etanercept (Enbrel) 5 0 1
Etanercept Biosimilar (Benepali) 104 40 15
Etanercept Biosimilar (Erelzi) 0 0 0
Golimumab (Simponi) 1 2 2
Guselkumab (Tremfya) 0 0 0
Infliximab [Flixabi] 0 0 0
Infliximab [Inflectra] 0 0 0
Infliximab [Remicade] 0 0 0
Infliximab [Remsima] 0 0 0
Ixekizumab (Taltz) 0 0 0
Rituximab (Mabthera) 0 0 0
Rituximab Biosimilar (Rixathon) 0 0 0
Rituximab Biosimilar (Truxima) 27 0 0
Sarilumab (Kevzara) 0 0 0
Secukinumab (Cosentyx) 0 11 5
Tildrakizumab (Ilumetri) 0 0 0
Tocilizumab (Ro Actemra) 38 0 0
Tofacitinib (Xeljanz) 0 0 0
Ustekinumab (Stelara) 0 0 6
Vedolizumab (Entyvio) 0 0 0

 

Treatment Psoriasis Crohns disease Ulcerative Colitis
Abatacept (Orencia) 0 0 0
Adalimumab biosimilar [Amgevita] 0 0 0
Adalimumab biosimilar [Hulio] 0 0 0
Adalimumab [Humira] 42 84 15
Adalimumab biosimilar [Hyrimoz] 0 0 0
Adalimumab biosimilar [Imraldi] 0 14 10
Apremilast (Otezla) 25 0 0
Baricitinib (Olumiant) 0 0 0
Brodalumab (Kyntheum) 0 0 0
Certolizumab (Cimzia) 0 0 0
Dimethyl Fumarate (Skilarence) 3 0 0
Etanercept (Enbrel) 2 0 0
Etanercept Biosimilar (Benepali) 1 0 0
Etanercept Biosimilar (Erelzi) 0 0 0
Golimumab (Simponi) 0 0 1
Guselkumab (Tremfya) 0 0 0
Infliximab [Flixabi] 0 2 1
Infliximab [Inflectra] 0 78 24
Infliximab [Remicade] 0 1 0
Infliximab [Remsima] 0 0 0
Ixekizumab (Taltz) 3 0 0
Rituximab (Mabthera) 0 0 0
Rituximab Biosimilar (Rixathon) 0 0 0
Rituximab Biosimilar (Truxima) 0 0 0
Sarilumab (Kevzara) 0 0 0
Secukinumab (Cosentyx) 23 0 0
Tildrakizumab (Ilumetri) 0 0 0
Tocilizumab (Ro Actemra) 0 0 0
Tofacitinib (Xeljanz) 0 0 0
Ustekinumab (Stelara) 19 19 0
Vedolizumab (Entyvio) 0 25 29

 

 

Protecting Your Online Privacy
Protecting Your Online Privacy

This Ashford and St Peter's website uses cookies to track visitor numbers. Find out more in our Cookies Policy and Privacy Policy. You can also read our Accessibility Statement and Privacy Notice for your information.